Julio R. Lopez, PharmD

Articles by Julio R. Lopez, PharmD

Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients

ByAmy Furman, PharmD,Joy L. Meier, PharmD,Robert A. Malmstrom, PharmD,Julio R. Lopez, PharmD,Saul Schaefer, MD

August 5th 2011

Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL.

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

ByJoy L. Meier, PharmD,Arthur L.M. Swislocki, MD,Julio R. Lopez, PharmD,Robert H. Noth, MD,Patricia Bartlebaugh, MSN,David Siegel, MD

June 1st 2002

Julio R. Lopez, PharmD

Articles by Julio R. Lopez, PharmD

Comparative Efficacy of Ezetimibe/Simvastatin, Rosuvastatin, and Atorvastatin in Uncontrolled Hyperlipidemia Patients

Reduction in Self-Monitoring of Blood Glucose in Persons with Type 2 Diabetes Results in Cost Savings and No Change in Glycemic Control

Latest Updated Articles

Trending on AJMC

ACP Names Semaglutide, Tirzepatide as First-Line Pharmacotherapy for Obesity

Type 5 Diabetes: A Long-Ignored Condition Gets Its Moment

CMS Proposes Permanent Rules for Medicare Drug Price Negotiation

CKD Stage, Proteinuria Tied to Higher HCRU in IgAN

Access and Disparity Questions Around Rilvegostomig+T-DXd: Coral Omene, MD, PhD